{"id":587916,"date":"2025-08-14T22:24:02","date_gmt":"2025-08-15T05:24:02","guid":{"rendered":"https:\/\/nai500.com\/blog\/2025\/08\/%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80etf%e6%8a%95%e8%b5%84%e6%8c%87%e5%8d%97%ef%bc%9a%e5%9b%9b%e5%8f%aa%e4%bc%98%e9%80%89%e5%9f%ba%e9%87%91%e8%a7%a3%e6%9e%90\/"},"modified":"2025-08-14T22:24:39","modified_gmt":"2025-08-15T05:24:39","slug":"%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80etf%e6%8a%95%e8%b3%87%e6%8c%87%e5%8d%97%ef%bc%9a%e5%9b%9b%e9%9a%bb%e5%84%aa%e9%81%b8%e5%9f%ba%e9%87%91%e8%a7%a3%e6%9e%90","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2025\/08\/%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80etf%e6%8a%95%e8%b3%87%e6%8c%87%e5%8d%97%ef%bc%9a%e5%9b%9b%e9%9a%bb%e5%84%aa%e9%81%b8%e5%9f%ba%e9%87%91%e8%a7%a3%e6%9e%90\/","title":{"rendered":"\u751f\u7269\u79d1\u6280ETF\u6295\u8cc7\u6307\u5357\uff1a\u56db\u96bb\u512a\u9078\u57fa\u91d1\u89e3\u6790"},"content":{"rendered":"

2025\u5e74\u4ee5\u4f86\uff0c\u751f\u7269\u79d1\u6280\u884c\u696d\u6301\u7e8c\u627f\u58d3\u3002\u5118\u7ba1\u5982\u6b64\uff0c\u751f\u7269\u79d1\u6280\u80a1\u7968\u4ecd\u4ee5\u9ad8\u6210\u9577\u6f5b\u529b\u5438\u5f15\u6295\u8cc7\u8005\uff0c\u77ed\u671f\u4f30\u503c\u512a\u52e2\u65e5\u76ca\u660e\u986f\uff0c\u800cAI\u9a45\u52d5\u7684\u85e5\u7269\u7814\u767c\u4ecd\u662f\u4e2d\u9577\u671f\u80a1\u50f9\u4e0a\u6f32\u7684\u50ac\u5316\u5291\u3002\u4f46\u662f\uff0c\u55ae\u4e00\u516c\u53f8\u7684\u6295\u8cc7\u98a8\u96aa\u5de8\u5927\uff0c\u751f\u7269\u79d1\u6280\u4ea4\u6613\u6240\u4ea4\u6613\u57fa\u91d1\uff08ETF\uff09\u80fd\u6709\u6548\u5206\u6563\u98a8\u96aa\uff0c\u662f\u53c3\u8207\u8a72\u9818\u57df\u9577\u671f\u589e\u9577\u7684\u7406\u6027\u5de5\u5177\u3002<\/p>\n

\u751f\u7269\u79d1\u6280\u884c\u696d\u5b58\u5728\u5169\u985e\u622a\u7136\u4e0d\u540c\u7684\u4f01\u696d\uff1a\u4e00\u65b9\u9762\uff0c\u5b89\u9032\uff08AMGN\uff09\u3001\u5409\u5229\u5fb7\u79d1\u5b78\uff08GILD\uff09\u3001\u798f\u6cf0\u88fd\u85e5\uff08VRTX\uff09\u548c\u518d\u751f\u5143\u88fd\u85e5\uff08REGN\uff09\u7b49\u5927\u578b\u85cd\u7c4c\u4f01\u696d\u8655\u65bc\u5546\u696d\u968e\u6bb5\uff0c\u53ef\u4ee5\u901a\u904e\u92b7\u552e\u85e5\u7269\u7372\u5f97\u7a69\u5b9a\u7684\u76c8\u5229\u548c\u73fe\u91d1\u6d41\uff0c\u7528\u65bc\u6301\u7e8c\u7814\u767c\u3001\u5408\u4f5c\u3001\u80a1\u7968\u56de\u8cfc\u6216\u5206\u7d05\u3002\u53e6\u4e00\u65b9\u9762\uff0c\u81e8\u5e8a\u968e\u6bb5\u7684\u751f\u7269\u79d1\u6280\u516c\u53f8\u901a\u5e38\u70ba\u4e2d\u5c0f\u5e02\u503c\u516c\u53f8\uff0c\u6536\u5165\u5fae\u8584\u751a\u81f3\u6c92\u6709\u6536\u5165\uff0c\u4f9d\u8cf4\u73fe\u91d1\u5132\u5099\u63a8\u9032\u85e5\u7269\u8a66\u9a57\u3002\u9019\u985e\u516c\u53f8\u7684\u56de\u5831\u5177\u6709\u6975\u7aef\u7684\u201c\u4e8c\u5143\u5316\u201d\u7279\u5fb5\uff1a\u53ef\u80fd\u5728\u591a\u5e74\u6d88\u8017\u73fe\u91d1\u548c\u7a00\u91cb\u80a1\u6b0a\u5f8c\u56e0\u8a66\u9a57\u6210\u529f\u6216\u85e5\u7269\u7372\u6279\u800c\u80a1\u50f9\u500d\u589e\uff0c\u4f46\u66f4\u591a\u6703\u56e0\u70ba\u8a66\u9a57\u5931\u6557\u6216\u76e3\u7ba1\u632b\u6298\u5c0e\u81f4\u4f30\u503c\u5d29\u6f70\u3002<\/p>\n

\u751f\u7269\u79d1\u6280\u516c\u53f8\u5931\u6557\u98a8\u96aa\u5f88\u9ad8\uff0c\u5275\u65b0\u9700\u7d93\u6b77\u591a\u5e74\u7684\u81e8\u5e8a\u8a66\u9a57\uff0c\u4e00\u6b21\u5931\u6557\u5c31\u53ef\u80fd\u6467\u6bc0\u516c\u53f8\u3002\u56e0\u6b64\uff0c\u8a72\u9818\u57df\u7684\u56de\u5831\u5dee\u7570\u5de8\u5927\uff0c\u6311\u9078\u8d0f\u5bb6\u500b\u80a1\u6975\u5176\u56f0\u96e3\u4e14\u98a8\u96aa\u5de8\u5927\u3002\u9019\u6642\u5019\u6295\u8cc7\u751f\u7269\u79d1\u6280ETF\u6709\u52a9\u65bc\u5c0d\u6c96\u8ca0\u9762\u4e8b\u4ef6\u98a8\u96aa\uff0c\u540c\u6642\u4ecd\u80fd\u986f\u8457\u53d7\u76ca\u4e8e\u91ab\u7642\u4fdd\u5065\u884c\u696d\u7684\u9577\u671f\u7d50\u69cb\u6027\u8f49\u8b8a\u3002<\/p>\n

\u56db\u96bb\u512a\u9078\u751f\u7269\u79d1\u6280ETF<\/h2>\n\n\n\n\n\n\n\n\n
ETF<\/strong>\u540d\u7a31<\/strong><\/td>\n\u8cbb\u7387<\/strong><\/td>\n\u6838\u5fc3\u7279\u5fb5<\/strong><\/td>\n<\/tr>\n<\/thead>\n
iShares\u751f\u7269\u79d1\u6280ETF (IBB)<\/a><\/strong><\/td>\n0.44%<\/td>\n– \u8ddf\u8e64\u5e02\u503c\u52a0\u6b0a\u6307\u6578\uff0c\u91cd\u5009\u5b89\u9032\/\u5409\u5229\u5fb7\u7b49\u5de8\u982d
\n– \u4e09\u5e74\u8c9d\u5854\u503c0.8\uff0c\u6ce2\u52d5\u4f4e\u65bc\u5927\u76e4<\/td>\n<\/tr>\n
First Trust NYSE Arca<\/strong>\u751f\u7269\u79d1\u6280\u6307\u6578\u57fa\u91d1<\/strong> (FBT)<\/strong><\/td>\n0.54%<\/td>\n– \u6309\u71df\u6536\u3001\u7814\u767c\u6295\u5165\u7b49\u57fa\u672c\u9762\u6307\u6a19\u7be9\u9078\u6210\u4efd\u80a1
\n– \u50c5\u7d0d\u5165\u8a55\u5206\u524d30\u540d\u7684\u4f01\u696d<\/td>\n<\/tr>\n
\u666f\u9806\u7d0d\u65af\u9054\u514b\u751f\u7269\u79d1\u6280<\/strong>ETF (IBBQ)<\/strong><\/td>\n0.19%<\/td>\n– \u8986\u84cb\u7d0d\u65af\u9054\u514b200\u9918\u5bb6\u751f\u7269\u91ab\u85e5\u80a1
\n– \u8207IBB\u6301\u5009\u91cd\u758a\u738780%\uff0c\u9069\u5408\u7a05\u6536\u640d\u5931\u6536\u5272\u7b56\u7565<\/td>\n<\/tr>\n
\u5168\u7403<\/strong>X<\/strong>\u57fa\u56e0\u7d44\u5b78\u548c\u751f\u7269\u79d1\u6280<\/strong>ETF (GNOM)<\/strong><\/td>\n0.50%<\/td>\n– \u5c08\u6ce8\u57fa\u56e0\u7de8\u8f2f\u3001\u6e2c\u5e8f\u7b49\u7d30\u5206\u9818\u57df
\n– \u6301\u5009\u4ee5\u4e2d\u578b\u4f01\u696d\u70ba\u4e3b\uff0c\u5982CRISPR(CRSP)\u3001Illumina (ILMN)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u4ee5\u4e0b\u662f\u9019\u56db\u96bb\u512a\u9078\u751f\u7269\u79d1\u6280ETF\u7684\u5177\u9ad4\u5206\u6790\uff1a<\/p>\n

    \n
  1. iShares<\/strong>\u751f\u7269\u79d1\u6280<\/strong>ETF (IBB) (<\/strong>\u8cbb\u7387\uff1a<\/strong>0.44%)<\/strong>\uff1a<\/strong>\u00a0IBB\u8ddf\u8e64\u5e02\u503c\u52a0\u6b0a\u7684\u7d10\u4ea4\u6240\u751f\u7269\u79d1\u6280\u6307\u6578NYSE Biotechnology Index\uff0c\u5b89\u9032\u3001\u5409\u5229\u5fb7\u548c\u518d\u751f\u5143\u7b49\u5927\u578b\u7a69\u5b9a\u7684\u516c\u53f8\u4f54\u64da\u4e3b\u8981\u6301\u5009\u3002\u56e0\u6b64\uff0c\u8a72\u57fa\u91d1\u6ce2\u52d5\u6027\u7565\u4f4e\u65bc\u5927\u76e4\uff0c\u4e09\u5e74\u8c9d\u5854\u503c\u70ba0.8\uff0c\u662f\u751f\u7269\u79d1\u6280\u6295\u8cc7\u65b0\u624b\u7684\u7406\u60f3\u9078\u64c7\u3002<\/li>\n
  2. First Trust NYSE Arca Biotechnology Index Fund (FBT) (<\/strong>\u8cbb\u7387\uff1a<\/strong>0.54%)<\/strong>\uff1a<\/strong>\u00a0FBT\u901a\u904eNYSE Arca Biotechnology Index\u63d0\u4f9b\u4e0d\u540c\u7684\u6295\u8cc7\u655e\u53e3\u3002\u8a72\u6307\u6578\u4e26\u975e\u50c5\u6309\u5e02\u503c\u52a0\u6b0a\uff0c\u800c\u662f\u6839\u64da12\u500b\u6708\u6536\u5165\u3001\u6de8\u92b7\u552e\u984d\u8207\u7814\u767c\u8cbb\u7528\u6bd4\u7387\u4ee5\u53ca12\u500b\u6708\u7814\u767c\u652f\u51fa\u7684\u767e\u5206\u6bd4\u8b8a\u5316\u5c0d\u7b26\u5408\u689d\u4ef6\u7684\u6210\u5206\u80a1\u9032\u884c\u6392\u540d\uff0c\u9078\u53d6\u5f97\u5206\u6700\u9ad8\u768430\u53ea\u80a1\u7968\u7d0d\u5165\u3002\u9019\u7a2e\u66f4\u8907\u96dc\u7684\u9078\u80a1\u65b9\u6cd5\u5e36\u4f86\u4e86\u76f8\u5c0d\u8f03\u9ad8\u7684\u8cbb\u7387\u3002<\/li>\n
  3. \u666f\u9806\u7d0d\u65af\u9054\u514b\u751f\u7269\u79d1\u6280<\/strong>ETF (IBBQ) (<\/strong>\u8cbb\u7387\uff1a<\/strong>0.19%)<\/strong>\uff1a<\/strong>\u00a0IBBQ\u8ddf\u8e64\u7d0d\u65af\u9054\u514b\u751f\u7269\u6280\u8853\u6307\u6578\uff0c\u8986\u84cb\u5728\u7d0d\u65af\u9054\u514b\u4ea4\u6613\u6240\u4e0a\u5e02\u7684\u6240\u6709\u751f\u7269\u6280\u8853\u548c\u88fd\u85e5\u80a1\uff0c\u8a72\u57fa\u6e96\u64c1\u6709\u8d85\u904e30\u5e74\u7684\u8ddf\u8e64\u8a18\u9304\u4e26\u6301\u6709200\u591a\u96bb\u80a1\u7968\u3002\u8207IBB\u985e\u4f3c\uff0c\u7531\u65bc\u63a1\u7528\u5e02\u503c\u52a0\u6b0a\u65b9\u6cd5\uff0c\u5409\u5229\u5fb7\u3001\u5b89\u9032\u3001\u798f\u6cf0\u548c\u518d\u751f\u5143\u540c\u6a23\u662f\u4e3b\u8981\u6301\u5009\u3002\u5118\u7ba1\u8ddf\u8e64\u7d0d\u65af\u9054\u514b\u548c\u7d10\u4ea4\u6240\u7684\u4e0d\u540c\u6307\u6578\uff0cIBBQ\u548cIBB\u7684\u6295\u8cc7\u7d44\u5408\u9ad8\u5ea6\u76f8\u4f3c\uff0c\u91cd\u758a\u7387\u7d0480%\u3002\u9019\u7a2e\u9ad8\u5ea6\u76f8\u4f3c\u6027\u4f7f\u5176\u6210\u70ba\u7406\u60f3\u7684\u7a05\u6536\u640d\u5931\u6536\u5272\uff08tax-loss harvesting\uff09\u642d\u6a94\u3002<\/li>\n
  4. Global X Genomics & Biotechnology ETF (GNOM) (<\/strong>\u8cbb\u7387\uff1a<\/strong>0.50%)<\/strong>\uff1a<\/strong>\u00a0GNOM\u5c08\u9580\u7d0d\u5165\u57fa\u56e0\u7d44\u5b78\u516c\u53f8\uff0c\u5373\u6bcf\u5bb6\u516c\u53f8\u81f3\u5c1150%\u7684\u73fe\u6709\u6216\u9810\u671f\u6536\u5165\u9700\u4f86\u81ea\u57fa\u56e0\u7de8\u8f2f\u3001\u57fa\u56e0\u7d44\u6e2c\u5e8f\u3001\u57fa\u56e0\u85e5\u7269\u548c\u7642\u6cd5\uff0c\u6216\u8a08\u7b97\u57fa\u56e0\u7d44\u5b78\u8207\u57fa\u56e0\u8a3a\u65b7\u3002\u4e0d\u540c\u65bcIBBQ\u548cIBB\uff0cGNOM\u7684\u6295\u8cc7\u7d44\u5408\u5305\u542b\u66f4\u591a\u65b0\u8208\u7684\u4e2d\u578b\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u5982\u958b\u767c\u57fa\u56e0\u7de8\u8f2f\u7642\u6cd5\u7684CRISPR Therapeutics AG (CRSP)\uff0c\u4ee5\u53ca\u57fa\u56e0\u6e2c\u5e8f\u9f8d\u982dIllumina\uff08ILMN\uff09\u3002<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    2025\u5e74\u4ee5\u4f86\uff0c\u751f\u7269\u79d1\u6280\u884c\u696d\u6301\u7e8c\u627f\u58d3\u3002\u5118\u7ba1\u5982\u6b64\uff0c\u751f\u7269\u79d1\u6280\u80a1\u7968\u4ecd\u4ee5\u9ad8\u6210\u9577\u6f5b\u529b\u5438\u5f15\u6295\u8cc7\u8005\uff0c\u77ed\u671f\u4f30\u503c\u512a\u52e2\u65e5\u76ca\u660e\u986f\uff0c\u800c […]<\/p>\n","protected":false},"author":27,"featured_media":555084,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[2191,809,927,564],"class_list":["post-587916","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-etf-tch","tag-809","tag-927","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/587916","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=587916"}],"version-history":[{"count":3,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/587916\/revisions"}],"predecessor-version":[{"id":587919,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/587916\/revisions\/587919"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/555084"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=587916"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=587916"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=587916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}